SCHEMBL2224976

SCHEMBL2224976

COc1ccc2c(S(=O)(=O)c3ccc(Br)c(NC4CCN(C)CC4)c3)c[nH]c2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.44
CYP3A4 P08684 5/20 0.42
TP53 P04637 1/20 0.41
EZH2 Q15910 2/20 0.41
HTR6 P50406 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
CYP2D6 P10635 3/20 0.39
DRD2 P14416 2/20 0.39
SLC6A2 P23975 2/20 0.39
HTR2A P28223 2/20 0.39
HTR2C P28335 2/20 0.39
HTR7 P34969 2/20 0.39
HRH1 P35367 2/20 0.39
ADRA1B P35368 2/20 0.39
SLC6A3 Q01959 2/20 0.39
KCNH2 Q12809 2/20 0.39
SLC6A4 P31645 1/20 0.39
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2222361 0.93 MAPT (0.53) MAPTCYP3A4TP53EZH2HTR6
SCHEMBL2220948 0.88 MAPT (0.41) MAPTCYP3A4TP53EZH2HTR6
SCHEMBL2266345 0.87 KCNH2 (0.43) CYP3A4HTR6DRD2KCNH2SLC6A4
SCHEMBL2222673 0.87 CYP3A4 (0.43) MAPTCYP3A4TP53EZH2HTR6
SCHEMBL2224555 0.86 KCNH2 (0.43) MAPTCYP3A4TP53EZH2HTR6
SCHEMBL2225214 0.86 CYP3A4 (0.49) CYP3A4TP53HTR6DRD2SLC6A2
SCHEMBL2223322 0.84 MAPT (0.53) MAPTCYP3A4TP53EZH2HTR6
SCHEMBL2223438 0.84 MAPT (0.53) MAPTCYP3A4TP53EZH2HTR6
SCHEMBL2223312 0.84 MAPT (0.56) MAPTCYP3A4TP53EZH2HTR6
Hydrochloric Acid SCHEMBL2223353 0.82 MAPT (0.52) MAPTCYP3A4TP53EZH2HTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2521714-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS Suven Life Sciences Limited (IN) 2012-11-14 EP claimed
WO-2011083487-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2011-07-14 WO claimed
US-9018231-B2 Sulfone compounds as 5-HT6 receptor ligands SUVEN LIFE SCIENCES LIMITED (IN) 2015-04-28 US disclosed
US-20130005709-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2013-01-03 US disclosed
EP-2521714-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS Suven Life Sciences Limited (IN) 2012-11-14 EP disclosed
WO-2011083487-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2011-07-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130005709-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS HTR6, HTR5A, HTR1A MAPT 509/4885CYP3A4 138/4885TP53 2499/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.